When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?

被引：0
作者：
Hardman, Morgan [1 ]
Gabriel, Emmanuel [2 ]
机构：
[1] Mayo Clin, Alix Sch Med, Jacksonville, FL USA
[2] Mayo Clin, Dept Surg, Div Surg Oncol, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
来源：
JOURNAL OF THORACIC DISEASE | 2023年 / 15卷 / 06期
关键词：
Renal cell; metastasis; surgery; CARCINOMA;
D O I：
10.21037/jtd-23-457
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：2896 / 2898
页数：3
相关论文
共 13 条
[1]   First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been? [J].
Adashek, Jacob J. ;
Breunig, Joshua J. ;
Posadas, Edwin ;
Bhowmick, Neil A. ;
Ellis, Leigh ;
Freedland, Stephen J. ;
Kim, Hyung ;
Figlin, Robert ;
Gong, Jun .
DRUGS, 2022, 82 (04) :439-453
[2]   Computational Modelling of Metastasis Development in Renal Cell Carcinoma [J].
Baratchart, Etienne ;
Benzekry, Sebastien ;
Bikfalvi, Andreas ;
Colin, Thierry ;
Cooley, Lindsay S. ;
Pineau, Raphael ;
Ribot, Emeline J. ;
Saut, Olivier ;
Souleyreau, Wilfried .
PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (11)
[3]   Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature [J].
Beirat, Amir F. ;
Menakuru, Sasmith R. ;
Khan, Ibrahim ;
Siddiqui, Salahuddin .
CASE REPORTS IN ONCOLOGY, 2023, 16 (01) :30-35
[4]   The combination of bevacizumab/Avastin and erlotinib/Tarceva is relevant for the treatment of metastatic renal cell carcinoma: the role of a synonymous mutation of the EGFR receptor [J].
Grepin, Renaud ;
Guyot, Melanie ;
Dumond, Aurore ;
Durivault, Jerome ;
Ambrosetti, Damien ;
Roussel, Jean-Francois ;
Dupre, Florence ;
Quintens, Herve ;
Pages, Gilles .
THERANOSTICS, 2020, 10 (03) :1107-1121
[5]   Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis [J].
Joshi, Shreyas S. ;
Handorf, Elizabeth A. ;
Zibelman, Matthew ;
Plimack, Elizabeth R. ;
Uzzo, Robert G. ;
Kutikov, Alexander ;
Smaldone, Marc C. ;
Geynisman, Daniel M. .
EUROPEAN UROLOGY, 2018, 74 (03) :387-393
[6]   Metastasectomy for Stage IVA Colon Cancer: Does the Type of Treating Institution Make a Difference? [J].
Kang, Shinho T. ;
Moran, Ryan ;
Hussain, Lala ;
Guend, Hamza ;
Dunki-Jacobs, Erik M. ;
Lee, David Y. .
AMERICAN SURGEON, 2022, 88 (08) :1976-1982
[7]   Metastasectomy in cutaneous melanoma [J].
Lasithiotakis, K. ;
Zoras, O. .
EJSO, 2017, 43 (03) :572-580
[8]   Surgery for thoracic oligoprogression in metastatic renal cell cancer in the era of new systemic therapies [J].
Le, Uyen-Thao ;
Passlick, Bernward ;
Schmid, Severin .
JOURNAL OF THORACIC DISEASE, 2023, 15 (03) :1133-1141
[9]   Metastatic Clear Cell Renal Cell Carcinoma: The Great Pretender and the Great Dilemma [J].
Maestroni, Umberto ;
Gasparro, Donatello ;
Ziglioli, Francesco ;
Guarino, Giulio ;
Campobasso, Davide .
WORLD JOURNAL OF ONCOLOGY, 2021, 12 (05) :178-182
[10]   Treatment Strategies for Oligometastatic Breast Cancer [J].
Nesbit, Eric G. ;
Donnelly, Eric D. ;
Strauss, Jonathan B. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
12